HENDERSON MICHAEL THOMAS

Average Profitability
7.23%
Insider Buys Quantity
1
Insider Buys Sum
$238,000.00
Insider Sells Quantity
24
Insider Sells Sum
$13.14M

Insider Activity of HENDERSON MICHAEL THOMAS

According to the SEC Form 4 filings, HENDERSON MICHAEL THOMAS, being in a position of

  1. Chief Executive Officer at Apogee Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 150000 shares for $7.37M,
    over all time since 2024-08-07, has bought 0 shares, and sold 150000 shares for $7.37M.

The largest purchase of all time was on 2019-07-01 and amounted to 14000 shares of BridgeBio Pharma, Inc. for $238,000.

The largest sale of all time was on 2024-10-02 and amounted to 40000 shares of Apogee Therapeutics, Inc. for $2.25M.

Biography of HENDERSON MICHAEL THOMAS

No biography is available at this moment.

2024-12-04SaleApogee Therapeutics, Inc.
APGE
Chief Executive Officer
15,000
0.0232%
$46.58$698,654-8.29%
2024-11-06SaleApogee Therapeutics, Inc.
APGE
Chief Executive Officer
15,000
0.0336%
$59.22$888,320-19.69%
2024-10-02SaleApogee Therapeutics, Inc.
APGE
Chief Executive Officer
40,000
0.0851%
$56.23$2.25M-7.49%
2024-09-04SaleApogee Therapeutics, Inc.
APGE
Chief Executive Officer
40,000
0.0721%
$47.62$1.9M+10.84%
2024-08-07SaleApogee Therapeutics, Inc.
APGE
Chief Executive Officer
40,000
0.0615%
$40.62$1.62M+23.88%
2020-12-01SaleBridgeBio Pharma, Inc.
BBIO
Chief Business Officer
10,000
0.0085%
$51.52$515,204+10.12%
2020-11-16SaleBridgeBio Pharma, Inc.
BBIO
Chief Business Officer
10,000
0.0086%
$45.00$450,000+27.01%
2020-11-02SaleBridgeBio Pharma, Inc.
BBIO
Chief Business Officer
10,000
0.0084%
$38.36$383,558+45.98%
2020-10-01SaleBridgeBio Pharma, Inc.
BBIO
Chief Business Officer
10,000
0.0083%
$38.83$388,342+42.18%
2020-09-18SaleBridgeBio Pharma, Inc.
BBIO
Chief Business Officer
20,000
0.016%
$40.00$800,000+33.47%
2020-09-01SaleBridgeBio Pharma, Inc.
BBIO
Chief Business Officer
20,000
0.0176%
$28.73$574,669+103.86%
2020-08-03SaleBridgeBio Pharma, Inc.
BBIO
Chief Business Officer
20,000
0.017%
$27.37$547,481+107%
2020-07-01SaleBridgeBio Pharma, Inc.
BBIO
Chief Business Officer
20,000
0.0173%
$30.97$619,403+81.15%
2020-06-08SaleBridgeBio Pharma, Inc.
BBIO
Chief Business Officer
1,212
0.001%
$30.01$36,371+66%
2020-06-03SaleBridgeBio Pharma, Inc.
BBIO
Chief Business Officer
1,568
0.0014%
$30.04$47,097+69.75%
2020-06-01SaleBridgeBio Pharma, Inc.
BBIO
Chief Business Officer
5,170
0.0045%
$29.37$151,823+67.07%
2020-05-05SaleBridgeBio Pharma, Inc.
BBIO
See Remarks
2,920
0.0025%
$30.47$88,987+30.24%
2020-05-04SaleBridgeBio Pharma, Inc.
BBIO
See Remarks
2,640
0.0023%
$30.01$79,227+33.66%
2020-05-01SaleBridgeBio Pharma, Inc.
BBIO
See Remarks
5,170
0.0045%
$29.27$151,307+38.14%
2020-04-01SaleBridgeBio Pharma, Inc.
BBIO
See Remarks
5,170
0.0047%
$26.94$139,258+54.07%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.